44 2033180199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Clinical Pharmacology and Toxicology Research

Sign up for email alert when new content gets added: Sign up

Utility of lipid sink in treatment of Refractory acquired Methemoglobinemia: A case report

2nd International Conference on TOXICOLOGY AND CLINICAL TOXICOLOGY

November 11-12, 2019 | London, UK

Anuj Khatri

Sri Ganga Ram Hospital, India

ScientificTracks Abstracts: Clin Pharmacol Toxicol Res

Abstract :

Methemoglobinemia can be congenital or acquired. Acquired methemoglobinemia occurs as a result of ingestion of some substances such as toluene, nitrates. Patient presents with cyanosis which is not explainable by the respiratory or cardiac cause. Most frequently used drug in treatment is methylene blue. We report a case of a patient with severe acquired methemoglobinemia in 14 months old baby, due to ingestion of toluene. He was cyanosed which was refractory to oxygen therapy and without any cardiac and respiratory disease. He had persistent high levels of methemoglobin, despite giving multiple doses of methylene blue and exchange transfusion. Finally, methemoglobin levels were controlled by automated RBC exchange transfusion and intralipid infusion.

Biography :

Anuj Khatri is working as a PICU Consultant in a tertiary care hospital in New Delhi. He is involved in the management of critically ill children admitted in Pediatric Intensive Care Unit, Cardiac Intensive Care Unit and transplant ICU. While working in PICU, he has been a part of the team who have managed different poisonings amongst children.

E-mail: dranujkhatri@gmail.com

 
Google Scholar citation report
Citations : 27

Clinical Pharmacology and Toxicology Research received 27 citations as per Google Scholar report

pulsus-health-tech
Top